-
341
SARS-CoV-2 SPIKE Antibody Levels can Indicate Immuno-Resilience to Re-infection: a Real-World Study
Published 2024-12-01Subjects: Get full text
Article -
342
Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19
Published 2022-01-01“…Upregulation of hsa_circ_0000479, RIG-I, and IL-6, and downregulation of hsa-miR-149-5p, along with correlation studies, indicate that hsa_circ_0000479/hsa-miR-149-5p/RIG-I, IL-6 axis could play a role in regulating the immune response against SARS-CoV-2. However, more studies are needed in this area.…”
Get full text
Article -
343
-
344
-
345
-
346
-
347
-
348
-
349
Identification of Bacterial Lipopolysaccharide-Associated Genes and Molecular Subtypes in Autism Spectrum Disorder
Published 2025-01-01Subjects: Get full text
Article -
350
A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA
Published 2025-01-01Subjects: Get full text
Article -
351
-
352
-
353
The probable progression of Epstein-Barr virus (EBV) to chronic active EBV/reactivation weakens the immune response and stimulates Cryptococcus neoformans infection, which invariably proves fatal: a case report and review of the literature
Published 2025-01-01“…We have reported here the fatal outcome of Epstein-Barr virus (EBV) infection in a 58-year-old male who had probably developed reactivation/chronic active EBV (CAEBV) which gave rise to various neurological deficits, pancytopenia, and a lower CD4 count in the patient. The decreased immune response helped Cryptococcus neoformans (C. neoformans) to manifest a disseminated infection. …”
Get full text
Article -
354
-
355
A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation
Published 2025-01-01“…NaBiVO3-PEG intratumorally administered initiates robust therapeutic efficacies against both primary and distant tumors and activates systemic immune responses to combat tumor metastasis. NaBiVO3-PEG intravenously administered can efficiently accumulate at the tumor site for further real-time computed tomography monitoring, immunotherapy, or alternative synergistic immune-radiotherapy. …”
Get full text
Article -
356
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster dosesResearch in context
Published 2025-03-01“…Here, we determined and compared in a longitudinal study the immune response elicited by SARS-CoV-2 vaccination across different groups of individuals who are immunocompromised. …”
Get full text
Article -
357
-
358
-
359
Generation, interrogation, and future applications of microglia-containing brain organoids
Published 2025-12-01Subjects: Get full text
Article -
360
Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer
Published 2025-01-01Subjects: Get full text
Article